Chenya Zhuo

Guangzhou, 510630, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Nanovesicles integrating PD-1-mediated targeting and CRISPR/Cas9-based CD47 editing for dual immune checkpoint blockade.

Nanovesicles integrating PD-1-mediated targeting and CRISPR/Cas9-based CD47 editing for dual immune checkpoint blockade.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 12, 2025

PD-1 monoclonal antibody (Tislelizumab)-induced DRESS syndrome in an intrahepatic cholangiocarcinoma patient with FGFR3 mutation and elevated IgG4:A case report.

PD-1 monoclonal antibody (Tislelizumab)-induced DRESS syndrome in an intrahepatic cholangiocarcinoma patient with FGFR3 mutation and elevated IgG4:A case report.

Journal: Clinical immunology (Orlando, Fla.)
Published: November 26, 2024

Mesenchymal stromal/stem cell spheroid-derived extracellular vesicles advance the therapeutic efficacy of 3D-printed vascularized artificial liver lobules in liver failure treatment.

Mesenchymal stromal/stem cell spheroid-derived extracellular vesicles advance the therapeutic efficacy of 3D-printed vascularized artificial liver lobules in liver failure treatment.

Journal: Bioactive materials
Published: September 09, 2024

Functionalized extracellular nanovesicles as advanced CRISPR delivery systems.

Functionalized extracellular nanovesicles as advanced CRISPR delivery systems.

Journal: Biomaterials science
Published: May 29, 2024

3D Printing of a Vascularized Mini-Liver Based on the Size-Dependent Functional Enhancements of Cell Spheroids for Rescue of Liver Failure.

3D Printing of a Vascularized Mini-Liver Based on the Size-Dependent Functional Enhancements of Cell Spheroids for Rescue of Liver Failure.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 17, 2023

Anti-phagocytosis-blocking repolarization-resistant membrane-fusogenic liposome (ARMFUL) for adoptive cell immunotherapy.

Anti-phagocytosis-blocking repolarization-resistant membrane-fusogenic liposome (ARMFUL) for adoptive cell immunotherapy.

Journal: Science advances
Published: August 09, 2023

A LIGHTFUL nanomedicine overcomes EGFR-mediated drug resistance for enhanced tyrosine-kinase-inhibitor-based hepatocellular carcinoma therapy.

A LIGHTFUL nanomedicine overcomes EGFR-mediated drug resistance for enhanced tyrosine-kinase-inhibitor-based hepatocellular carcinoma therapy.

Journal: Biomaterials
Published: July 02, 2023

Highly efficient fabrication of functional hepatocyte spheroids by a magnetic system for the rescue of acute liver failure.

Highly efficient fabrication of functional hepatocyte spheroids by a magnetic system for the rescue of acute liver failure.

Journal: Biomaterials
Published: November 10, 2022

Engineered virus-like particles: paving the way for effective somatic genome editing.

Engineered virus-like particles: paving the way for effective somatic genome editing.

Journal: Signal transduction and targeted therapy
Published: June 07, 2022

OSI-906 restores the sensitivity of ovarian clear cell carcinoma to cisplatin by targeting the IGF1R/AKT pathway.

OSI-906 restores the sensitivity of ovarian clear cell carcinoma to cisplatin by targeting the IGF1R/AKT pathway.

Journal: Medical oncology (Northwood, London, England)
Published: June 22, 2021

Spatiotemporal control of CRISPR/Cas9 gene editing.

Spatiotemporal control of CRISPR/Cas9 gene editing.

Journal: Signal transduction and targeted therapy
Published: November 02, 2020

Effects of the structures and micropores of sedimentary organic matter on the oxidative degradation of benzo(a)pyrene by Na2S2O8.

Effects of the structures and micropores of sedimentary organic matter on the oxidative degradation of benzo(a)pyrene by Na2S2O8.

Journal: Water research
Published: September 26, 2019
Showing 1-12 of 13

Last Updated: 09/26/2026